|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-1-28
|
|
pubmed:abstractText |
Griseofulvin has been the mainstay of treatment for tinea imbricata (TI) for decades; however, there have been few reports of efficacy of newer antifungals in the treatment of this condition. Many patients with TI have several obstacles to treatment due to their remote geographical locations and the primitive nature of their societies.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
150
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
119-26
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14746625-Adolescent,
pubmed-meshheading:14746625-Adult,
pubmed-meshheading:14746625-Aged,
pubmed-meshheading:14746625-Antifungal Agents,
pubmed-meshheading:14746625-Child,
pubmed-meshheading:14746625-Female,
pubmed-meshheading:14746625-Fluconazole,
pubmed-meshheading:14746625-Griseofulvin,
pubmed-meshheading:14746625-Humans,
pubmed-meshheading:14746625-Itraconazole,
pubmed-meshheading:14746625-Male,
pubmed-meshheading:14746625-Middle Aged,
pubmed-meshheading:14746625-Naphthalenes,
pubmed-meshheading:14746625-Prospective Studies,
pubmed-meshheading:14746625-Skin,
pubmed-meshheading:14746625-Tinea,
pubmed-meshheading:14746625-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole.
|
|
pubmed:affiliation |
Department of Dermatology, Louisiana State University Health Sciences Center, 1542 Tulane Avenue, New Orleans, LA 70112, U.S.A.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
